NAUT
NAUT
NASDAQ · Life Sciences Tools & Services

Nautilus Biotechnology Inc

$2.14
-0.29 (-11.93%)
As of Nov 19, 8:35 PM ET ·
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Buy 7 88%
Hold 1 13%
Sell 0 0%
Price Target
Analyst Price Target +1,141.1% upside
Low Target $24.26
Average Target $26.56
High Target $41.87
Current Price $2.14
Current
$2.14
Target
$26.56
$24.26 $26.56 avg $41.87
Scenario Analysis
Bear Case
$24.26
1,033.6%
Low target
Base Case
$26.56
+1,141.1%
Avg target
Bull Case
$41.87
+1,856.5%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$4.31
-50.3% from high
52-Week Low
$0.84
+154.4% from low
Target vs 52W High
$26.56
+516.2% vs high
Peer Consensus — Life Sciences Tools & Services
Stock Consensus Analysts Buy % Target Upside
TMO
Thermo Fisher Scientific Inc
Strong Buy 34 79% $369.21 -46.4%
DHR
Danaher Corp
Strong Buy 31 84% $158.11 -30.5%
A
Agilent Technologies Inc
Buy 30 73% $64.69 -63.1%
WAT
Waters Corp
Strong Buy 28 75% $189.60 -58.5%
IQV
Iqvia Holdings Inc
Strong Buy 26 92% $82.96 -66.9%
MTD
Mettler-Toledo International
Hold 19 47% $170.43 -90.0%
ILMN
Illumina Inc
Hold 28 54% $169.36 -15.6%
WST
West Pharmaceutical Services
Strong Buy 21 95% $136.24 -65.7%